Cato Research is a full-service contract research and development organization with international resources dedicated to helping pharmaceutical and biotechnology companies efficiently and expeditiously navigate the regulatory approval process in order to bring new drugs, biologics, and medical devices to the people who need them.
» Cato Research Overview | Contact Us
April 15, 2013 - Cancer Advances Announces Issuance of Three New Patents to Its Suite of Gastrin Inhibitor Products ![]()
January 22, 2013 - Cato Research and Cato BioVentures Announces the Opening of Houston, Texas, Office ![]()
January 7, 2013 - Join Cato BioVentures and Cancer Advances at Biotech Showcase 2013 & J.P. Morgan 31st Annual Healthcare Conference ![]()